Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on pancreatic cancer.

Conor J Magee1, Ali Shekouh, Paula Ghaneh

  • 1University of Liverpool, Department of Surgery, Royal Liverpool, University Hospital, Liverpool L69 3GA.

Hospital Medicine (London, England : 1998)
|May 9, 2002
PubMed
Summary

Pancreatic cancer remains a major global health challenge. Advances in surgical and adjuvant treatments offer improved quality of life and survival for patients with this disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Lancet (London, England)·2026
Same author

Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC).

European journal of cancer (Oxford, England : 1990)·2026
Same author

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service.

British journal of cancer·2026
Same author

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Hepatobiliary surgery and nutrition·2026
Same author

The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy Mortality.

Annals of surgery·2026
Same author

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.

The Lancet. Oncology·2025

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Oncology

Background:

  • Pancreatic cancer is a leading cause of cancer mortality globally.
  • Surgical resection and adjuvant therapies are crucial for improving patient outcomes.
  • Understanding the disease's progression is key to developing effective treatments.

Purpose of the Study:

  • To review recent advancements in pancreatic cancer research.
  • To discuss current clinical management strategies.
  • To highlight novel treatment and screening approaches.

Main Methods:

  • Comprehensive literature review of pancreatic cancer research.
  • Analysis of current clinical guidelines and practices.
  • Evaluation of emerging therapeutic and diagnostic technologies.

Main Results:

  • Significant progress has been made in understanding pancreatic cancer development.
  • Current management involves a multidisciplinary approach combining surgery and adjuvant therapy.
  • Novel treatment modalities and screening techniques show promise.

Conclusions:

  • Continued research into pancreatic cancer biology is essential.
  • Optimizing current treatment protocols can enhance patient survival and quality of life.
  • Early detection through advanced screening methods is critical for improving prognosis.

Related Experiment Videos